미세먼지 in vivo 모델에서 호흡기 질환에 대한 한약의 효과에 관한 연구 동향 분석

키워드

참고문헌 (72)

1. The economic consequences of outdoor air pollution, "OECD", ~ (2016)
2. 변가람, "지역간 상대위험도 변동을 고려한 미세먼지 기인 질병부담 및 사회경제적 비용 추정 연구", 한국환경보건학회지, 47(5), pp.486~495 (2021), 한국환경보건학회[DOI]
3. Pope CA 3rd, "Health effects of fine particulate air pollution : lines that connect", Journal of the air & waste management association, 56(6), pp.709~742 (2006)
4. World Health Organization, "Air pollution including WHO's 1999 guidelines for air pollution control", World Health Organization, ~ (2000)
5. Shin DC, "Health effects of ambient particulate matter", Journal of the Korean Medical Association, 50(2), pp.175~182 (2007)
6. 명준표, "미세먼지와 건강 장애", 대한내과학회지, 91(2), pp.106~113 (2016), 대한내과학회[DOI]
7. Chang CJ, "Relationship between air pollution and outpatient visits for nonspecific conjunctivitis", Investigative ophthalmology & visual science, 53(1), pp.429~433 (2012)
8. Hu R, "PM2.5 exposure elicits oxidative stress responses and mitochondrial apoptosis pathway activation in HaCaT keratinocytes", Chinese medical journal, 130(18), pp.2205~2214 (2017)
9. 경선영, "미세먼지", 황사 건강피해 예방 및 권고지침: 호흡기질환, 2015, pp.58(11), 1060~1069[DOI]
10. Liu S, "Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease : results from a cross-sectional study in China", Thorax, 72(9), pp.788~795 (2017)
11. Keet CA, "Long-term coarse particulate matter exposure is associated with asthma among children in Medicaid", American journal of respiratory and critical care medicine, 197(6), pp.737~746 (2018)
12. Hamra GB, "Outdoor particulate matter exposure and lung cancer : a systematic review and meta-analysis", Environmental health perspectives, 122(9), pp.906~911 (2014)
13. Hou W, "Gu-Ben-Zhi-Ke-Zhong-Yao Alleviated PM2.5-Induced Lung Injury via HMGB1", NF-κB Axis, 2022, pp.2022, 8450673~
14. Chen L, "The protective effects of Shengmai formula against myocardial injury induced by ultrafine particulate matter exposure and myocardial ischemia are mediated by the PI3K", AKT, Nrf2 pathway, pp.Frontiers in Pharmacology, 2021[DOI]
15. Sharma P, "A Systematic Review on Particulate Matter Induced Disease and Herbs Useful in Lung Tissue Damage", Journal of Survey in Fisheries Sciences, 10(2S), pp.933~947 (2023)
16. Jing Y, "Bufei huoxue capsule attenuates PM2.5-induced pulmonary inflammation in mice", Evidence-Based Complementary and Alternative Medicine, 2017, pp.1575793~ (2017)
17. 이철화, "만성폐쇄성폐질환 및 미세먼지 유발 폐손상 동물모델에서 과루행련환의 효과", 대한한방내과학회지, 38(3), pp.353~366 (2017), 대한한방내과학회
18. Zhang J, "Therapeutic effects of stemonine on particulate matter 2.5-induced chronic obstructive pulmonary disease in mice", Experimental and Therapeutic Medicine, 14(5), pp.4453~4459 (2017)
19. Lee WH, "Inhibitory effects of Kyung-Ok-Ko, traditional herbal prescription, on particulate matter-induced vascular barrier disruptive responses", International journal of environmental health research, 29(3), pp.301~311 (2019)
20. Liu T, "Protective effect of Colla corii asini against lung injuries induced by intratracheal instillation of artificial fine particles in rats", International journal of molecular sciences, 20(1), pp.55~ (2018)
21. Liu Z, "Number 2 Feibi recipe reduces PM2.5-induced lung injury in rats", Evidence-Based Complementary and Alternative Medicine, 2018, pp.3674145~ (2018)
22. Xia Y, "YiQiFuMai lyophilized injection attenuates particulate matter-induced acute lung injury in mice via TLR4-mTOR-autophagy pathway", Biomedicine & Pharmacotherapy, 108, pp.906~913 (2018)
23. Zhang JB, "Tubeimoside I attenuates inflammation and oxidative damage in a mice model of PM2.5-induced pulmonary injury", Experimental and Therapeutic Medicine, 15(2), pp.1602~1607 (2018)
24. Fei Y, "Ma Xing Shi Gan decoction attenuates PM2.5 induced lung injury via inhibiting HMGB1", TLR4, Frontiers in Pharmacology, pp.2019, 10[DOI]
25. Wonhwa Lee, "Pulmonary Protective Functions of Rare Ginsenoside Rg4 on Particulate Matter-induced Inflammatory Responses", Biotechnology and Bioprocess Engineering, 24(3), pp.445~453 (2019), 한국생물공학회[DOI]
26. Li C, "Preventive effect of ursolic acid derivative on particulate matter 2.5-induced chronic obstructive pulmonary disease involves suppression of lung inflammation", IUBMB life, 72(4), pp.632~640 (2020)
27. Xu Y, "Antitussive and anti-inflammatory dual-active agents developed from natural product lead compound 1-methylhydantoin", Molecules, 24(13), pp.2355~ (2019)
28. 한수현, "미세먼지로 유도된 기관지염증에 다시마가 함유된 복합물의 효과", 동의생리병리학회지, 34(5), pp.245~254 (2020), 한의병리학회[DOI]
29. Lee YS, "Standardized herbal extract PM014 alleviates fine dust-induced lung inflammation in mice", BMC Complementary Medicine and Therapies, 20(1), pp.270~ (2020)
30. Wang Y, "5-induced lung injury by reducing pulmonary cell apoptosis through Akt", mTOR, Bioscience Reports, pp.2020, 40(7)[DOI]
31. Wang Y, "5-induced lung injury through suppression of epithelial-to-mesenchymal transition(EMT)and epithelial barrier disruption", Evidence-Based Complementary and Alternative Medicine, 2020, pp.7176589~ (2020)
32. 양원경, "Protective Effect of GHX02 Extract on Particulate Matter-Induced Lung Injury", Journal of Medicinal Food, 23(6), pp.611~632 (2020), 한국식품영양과학회[DOI]
33. Pei C, "5-induced lung injury by regulating autophagy via inhibition of PI3K", Akt, Journal of inflammation research, pp.2021, 14[DOI]
34. Wang Y, "Ruscogenin attenuates particulate matter-induced acute lung injury in mice via protecting pulmonary endothelial barrier and inhibiting TLR4 signaling pathway", Acta Pharmacologica Sinica, 42(5), pp.726~734 (2021)
35. Cao L, "Study on lung injury caused by fine particulate matter and intervention effect of rhodiola wallichiana", Evidence-Based Complementary and Alternative Medicine, 2022, pp.3693231~ (2022)
36. Deng L, "Protective effect and mechanism of baicalin on lung inflammatory injury in BALB", cJ mice induced by PM2.5, 2022, pp.248, 114329~
37. Huang D, "Astragaloside IV alleviates PM2.5-caused lung toxicity by inhibiting inflammasome-mediated pyroptosis via NLRP3", caspase-1 axis inhibition in mice, 2022, pp.150, 112978~
38. 김채영, "The Inhibitory Functions of Sparstolonin B against Ambient Fine Particulate Matter Induced Lung Injury", Biotechnology and Bioprocess Engineering, 27(6), pp.949~960 (2022), 한국생물공학회[DOI]
39. 김수현, "미세먼지 유발 폐기능 손상 동물모델에서 RML의 호흡기 보호 효과", 대한본초학회지, 37(3), pp.29~39 (2022), 대한본초학회
40. Lee JS, "Anti-Apoptotic and Anti-Inflammatory Effects of an Ethanolic Extract of Lycium chinense Root against Particulate Matter 10-Induced Cell Death and Inflammation in RBL-2H3 Basophil Cells and BALB", c Mice, 2022, pp.11(19), 2485~
41. Park SM, "Adenophora Stricta Root Extract Protects Lung Injury from Exposure to Particulate Matter 2.5 in Mice", Antioxidants, 11(7), pp.1376~ (2022)
42. Wang Y, "Sipeimine ameliorates PM2.5-induced lung injury by inhibiting ferroptosis via the PI3K", Akt, Ecotoxicology and Environmental Safety, pp.2022, 239[DOI]
43. Won-Kyung Yang, "Respiratory protective effects of Korean Red Ginseng in a mouse model of particulate matter 4-induced airway infl ammation", Journal of Ginseng Research, 47(1), pp.81~88 (2023), 고려인삼학회
44. Wang P, "Effect of San'ao decoction on aggravated asthma mice model induced by PM2.5 and TRPA1", TRPV1expressions, 2019, pp.236, 82~90
45. Nam YK, "Banhahubak-Tang tablet, a standardized medicine attenuates allergic asthma via inhibition of janus kinase 1(JAK1)", signal transducer and activator of transcription 6(STAT6)signal pathway, 2020, pp.25(9), 2206~
46. Li J, "Effective-component compatibility of Bufei Yishen formula protects COPD rats against PM2.5-induced oxidative stress via miR-155", FOXO3a pathway, 2021, pp.228, 112918~
47. Han JM, "Exploring the Potential Effects and Mechanisms of Asarum sieboldii Radix Essential Oil for Treatment of Asthma", Pharmaceutics, 14(3), pp.558~ (2022)
48. Ko HM, "Rosa laevigata Attenuates Allergic Asthma Exacerbated by Water-Soluble PM by Downregulating the MAPK Pathway", Frontiers in Pharmacology, 13, pp.925502~ (2022)
49. Pope CA 3rd, "Mortality effects of longer term exposures to fine particulate air pollution : review of recent epidemiological evidence", Inhalation toxicology, 19(sup1), pp.33~38 (2007)
50. Loomis D, "The International Agency for Research on Cancer(IARC)evaluation of the carcinogenicity of outdoor air pollution : focus on China", Chinese journal of cancer, 33(4), pp.189~196 (2014)
51. Kim KN, "Effects of short-term fine particulate matter exposure on acute respiratory infection in children", International journal of hygiene and environmental health, 229, pp.113571~ (2020)
52. Turner MC, "Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers", American journal of respiratory and critical care medicine, 184(12), pp.1374~1381 (2011)
53. 여민주, "우리나라 미세먼지 농도 추이와 고농도 발생 현황", 한국대기환경학회지, 35(2), pp.249~264 (2019), 한국대기환경학회[DOI]
54. Chen R, "Qianjinweijing Decoction Protects Against Fine Particulate Matter Exposure-mediated Lung Function Disorder", Frontiers in Pharmacology, 13, pp.873055~ (2022)
55. 유이란, "미세먼지 관련 호흡기질환 임상연구 동향", 대한한방내과학회지, 40(3), pp.443~457 (2019), 대한한방내과학회[DOI]
56. Hadei M, "Cardiovascular effects of airborne particulate matter : a review of rodent model studies", Chemosphere, 242, pp.125204~ (2020)
57. Reiss Y, "CC chemokine receptor(CCR)4and the CCR10 ligand cutaneous T cellattracting chemokine(CTACK)in lymphocyte trafficking to inflamed skin", The Journal of experimental medicine, 194(10), pp.1541~1547 (2001)
58. Li Y, "A rat model for stable chronic obstructive pulmonary disease induced by cigarette smoke inhalation and repetitive bacterial infection", Biological and Pharmaceutical Bulletin, 35(10), pp.1752~1760 (2012)
59. Curbani F, "Inhale, exhale : Why particulate matter exposure in animal models are so acute", Environmental Pollution, 251, pp.230~237 (2019)
60. 이현주, "한반도 미세먼지 발생과 연관된 대기패턴 그리고 미래 전망", 한국기후변화학회지, 9(4), pp.423~433 (2018), 한국기후변화학회[DOI]
61. Ahmed MH, "Dexamethasone for the treatment of coronavirus disease(COVID-19) : a review", SN comprehensive clinical medicine, 2(12), pp.2637~2646 (2020)
62. Villar J, "Dexamethasone treatment for the acute respiratory distress syndrome : a multicentre, randomised controlled trial", The Lancet Respiratory Medicine, 8(3), pp.267~276 (2020)
63. Keeney GE, "Dexamethasone for acute asthma exacerbations in children : a meta-analysis", Pediatrics, 133(3), pp.493~499 (2014)
64. Ardestani ME, "Methyl prednisolone vs dexamethasone in management of COPD exacerbation; a randomized clinical trial", Emergency, 5(1), pp.e35~ (2017)
65. Vaughan A, "The effect of diesel emission exposure on primary human bronchial epithelial cells from a COPD cohort : N-acetylcysteine as a potential protective intervention", Environmental research, 170, pp.194~202 (2019)
66. Millman M, "Use of acetylcysteine in bronchial asthma--another look", Annals of allergy, 54(4), pp.294~296 (1985)
67. Hsieh CF, "Mechanism by which ma-xing-shigan-tang inhibits the entry of influenza virus", Journal of ethnopharmacology, 143(1), pp.57~67 (2012)
68. Liao YN, "The use of Chinese herbal medicine in the treatment of chronic obstructive pulmonary disease(COPD)", The American journal of Chinese medicine, 45(02), pp.225~238 (2017)
69. Zhang J, "Astragaloside IV derived from Astragalus membranaceus : a research review on the pharmacological effects", Advances in Pharmacology, 87, pp.89~112 (2020)
70. Yang X, "The effect of astragaloside IV on JAK2-STAT6 signalling pathway in mouse model of ovalbumin-induced asthma", Journal of animal physiology and animal nutrition, 103(5), pp.1578~1584 (2019)
71. Li LC, "Astragaloside IV improves bleomycininduced pulmonary fibrosis in rats by attenuating extracellular matrix deposition", Frontiers in Pharmacology, 8, pp.513~ (2017)
72. Ristovski ZD, "Respiratory health effects of diesel particulate matter", Respirology, 17(2), pp.201~212 (2012)

관련 논문AI추천